These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27493024)

  • 21. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza Virus Shedding in Laninamivir-Treated Children upon Returning to School.
    Kondo H; Shobugawa Y; Hibino A; Yagami R; Dapat C; Okazaki M; Otsuka T; Fujii K; Hassan MR; Saito R
    Tohoku J Exp Med; 2016 Feb; 238(2):113-21. PubMed ID: 26806610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance.
    Nakano T; Okumura A; Tanabe T; Niwa S; Fukushima M; Yonemochi R; Eda H; Tsutsumi H
    Scand J Infect Dis; 2013 Jun; 45(6):469-77. PubMed ID: 23373850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2016 Sep; 22(9):599-604. PubMed ID: 27346379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza.
    Kashiwagi S; Watanabe A; Ikematsu H; Uemori M; Awamura S;
    Clin Infect Dis; 2016 Aug; 63(3):330-7. PubMed ID: 27118785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
    Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):89-97. PubMed ID: 22907567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
    Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
    PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate for Inhalation Suspension Set in children under the age of 5 in a post-marketing surveillance.
    Nakano T; Yamaguchi H; Chiba T; Shiosakai K; Chikada S; Matsuoka Y
    J Infect Chemother; 2021 Oct; 27(10):1436-1446. PubMed ID: 34226112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial.
    Kashiwagi S; Watanabe A; Ikematsu H; Awamura S; Okamoto T; Uemori M; Ishida K
    J Infect Chemother; 2013 Aug; 19(4):740-9. PubMed ID: 23732307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced pneumonitis following the administration of laninamivir octanoate: The first two reported cases.
    Ogawa T; Tanaka K; Ohgino K; Omori N; Betsuyaku T; Sayama K
    J Infect Chemother; 2019 Dec; 25(12):1043-1046. PubMed ID: 31178281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapulmonary Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Nebulized Administration of Laninamivir Octanoate in Healthy Japanese Subjects.
    Toyama K; Furuie H; Ishizuka H
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the clinical effectiveness of three neuraminidase inhibitors for Japanese pediatric patients with influenza in the 2013/2014 season].
    Hishiki H; Ishiwada N; Naito S; Nagasawa K; Someya T; Inoue N; Haraki M; Kurosaki T; Kameoka Y; Suzuki K
    Jpn J Antibiot; 2015 Dec; 68(6):337-43. PubMed ID: 27004397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.
    Zaraket H; Dapat C; Ghanem S; Ali Z; Lteif M; Kondo H; Dapat IC; Saito K; Kayali G; Suzuki H; Dbaibo G; Saito R
    Intervirology; 2014; 57(6):344-52. PubMed ID: 25301400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhaled Laninamivir Octanoate as Prophylaxis for Influenza in Children.
    Nakano T; Ishiwada N; Sumitani T; Uemori M; Isobe K;
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.